Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Flexyn2a
BIOLOGICAL
2 trials
Sponsors
LimmaTech Biologics AG
Conditions
Shigellosis
Phase 1
Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
Completed
NCT02388009
LimmaTech Biologics AG
Shigellosis
Start: 2015-02-28
End: 2015-09-30
Updated: 2015-12-22
Phase 2
Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Completed
NCT02646371
LimmaTech Biologics AG
Shigellosis
Start: 2015-12-31
End: 2017-07-31
Updated: 2021-01-27
Related Papers
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
EBioMedicine
2021-04-01
77 citations
Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
EBioMedicine
2021-04-01
4 citations
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
Clinical and Vaccine Immunology
2016-09-01
140 citations